Timing of Pegfilgrastim: Association with Febrile Neutropenia in a Pediatric Solid and CNS Tumor Population

INIS

• patients 80%
• administration 70%
• chemotherapy 70%
• solids 20%
• tumors 20%
• pediatrics 20%
• barriers 20%
• data 10%
• risks 10%
• adults 10%
• populations 10%
• reviews 10%
• toxicity 10%
• charts 10%
• central nervous system 10%
• randomness 10%

Nursing and Health Professions

• Chemotherapy 70%
• Patient 60%
• Febrile Neutropenia 50%
• Central Nervous System Tumor 20%
• Treatment Outcome 10%
• Toxicity 10%
• Solid Malignant Neoplasm 10%
• Independent Variable 10%
• Pediatrics Patient 10%
• Procedures 10%
• Pediatrics 10%
• Adult 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Pegfilgrastim 100%
• Febrile Neutropenia 50%
• Central Nervous System Tumor 20%
• Toxicity 10%
• Pharmacokinetics 10%
• Solid Malignant Neoplasm 10%
• Mixed Model 10%